Global Materials | Industrials | Commodities

Rahul Jain

Equity Bottom-Up

<ul>
<li>Zijin has acquired one of Kazakhstan’s largest gold mines, Raygorodok, adding 3.2 Moz in reserves and 193 koz in annual production.</li>
<li>He asset is highly profitable (USD 202m net profit in 2024) with low costs (USD 796/oz), lifting Zijin’s output by 8% and reserves by 4%.</li>
<li>5.9x P/E and 3.3x EV/EBITDA, the deal looks attractively priced and enhances the scale, margins, and IPO narrative for Zijin Gold International.</li>
</ul>


Zijin has acquired one of Kazakhstan’s largest gold mines, Raygorodok, adding 3.2 Moz in reserves and 193 koz in annual production.
He asset is highly profitable (USD 202m net profit in 2024) with low costs (USD 796/oz), lifting Zijin’s output by 8% and reserves by 4%.
5.9x P/E and 3.3x EV/EBITDA, the deal looks attractively priced and enhances the scale, margins, and IPO narrative for Zijin Gold International.


Zijin Mining (601899.SS): Acquires Kazakhstan’s Raygorodok Gold Mine for USD 1.2 Billion

<ul>
<li>Zijin plans to IPO its overseas gold unit, targeting 85t output in 2025; timeline not yet disclosed.</li>
<li>SOTP values copper business at RMB 592 bn, gold at RMB 190–200 bn, lithium adds RMB 18–28 bn.</li>
<li>Stock trades ~15–20% below intrinsic value, offering ~25–26% upside even without IPO re-rating.</li>
</ul>


Zijin plans to IPO its overseas gold unit, targeting 85t output in 2025; timeline not yet disclosed.
SOTP values copper business at RMB 592 bn, gold at RMB 190–200 bn, lithium adds RMB 18–28 bn.
Stock trades ~15–20% below intrinsic value, offering ~25–26% upside even without IPO re-rating.


Zijin Mining (2899 HK): Fair Value Still 25% Higher Despite IPO Discount Risks

<ul>
<li>A 4–6 month Kakula disruption could reduce Zijin’s 2025 copper output by 4–8%, cutting EBITDA by ~7–11%.</li>
<li>Ramp-Ups at Julong and Čukaru Peki can offset ~60–70% of the lost volume and partially protect margins.</li>
<li>Lithium is expected to grow from 8% to 20% of EBITDA by 2028, driven by 300kt LCE capacity from low-cost brine assets.</li>
</ul>


A 4–6 month Kakula disruption could reduce Zijin’s 2025 copper output by 4–8%, cutting EBITDA by ~7–11%.
Ramp-Ups at Julong and Čukaru Peki can offset ~60–70% of the lost volume and partially protect margins.
Lithium is expected to grow from 8% to 20% of EBITDA by 2028, driven by 300kt LCE capacity from low-cost brine assets.


Zijin Mining (601899 CH / 2899 HK): Evaluating the Impact of Kakula Suspension

Pan-Asia Catalysts/Events, Quiddity Advisors

David Blennerhassett

Pan-Asia Catalysts/Events

Quiddity Advisors

Event-Driven

<ul>
<li>On the 6th October, West African mid-tier gold play <a href="https://www.smartkarma.com/entities/predictive-discovery-ltd" target="_blank" data-smartkarma-citation="entities:15374:1" rel="noopener">Predictive Discovery (PDI AU)</a> announced scrip-merger with <a href="https://www.smartkarma.com/entities/robex-resources-inc-5fcb5aec-772d-4972-be7e-30cad5c02e26" target="_blank" data-smartkarma-citation="entities:45881:1" rel="noopener">Robex Resources (RBX CN/RBX AU)</a>. Upon completion, PDI would hold 51% of shares out.</li>
<li>Immediately, rumours circled in local media that <a href="https://www.smartkarma.com/entities/perseus-mining-ltd" target="_blank" data-smartkarma-citation="entities:15306:1" rel="noopener">Perseus Mining (PRU AU)</a>, PDI's largest shareholder (17.8%), was poised to launch its own offer. That has now unfolded. </li>
<li>Perseus is offering 0.1360 new Perseus share for every PDI share, or an indicative consideration of A$0.778/share. PDI deemed terms superior. Robex has matching rights under its definitive agreement.</li>
</ul>


On the 6th October, West African mid-tier gold play Predictive Discovery (PDI AU) announced scrip-merger with Robex Resources (RBX CN/RBX AU). Upon completion, PDI would hold 51% of shares out.
Immediately, rumours circled in local media that Perseus Mining (PRU AU), PDI's largest shareholder (17.8%), was poised to launch its own offer. That has now unfolded. 
Perseus is offering 0.1360 new Perseus share for every PDI share, or an indicative consideration of A$0.778/share. PDI deemed terms superior. Robex has matching rights under its definitive agreement.


Predictive: Perseus Pitches Preferred Proposal

Pan-Asia Index Rebalances/ Events/ Delta One, Periscope Analytics

Brian Freitas

Pan-Asia Index Rebalances/ Events/ Delta One

Periscope Analytics

Periscope Analytics focuses on event-driven trades across Asia Pacific and provides comprehensive, timely and systematic coverage of index changes to major Asia Pacific indices in a structured manner.

The analysis includes forecasted inclusions and exclusions to all major Asian indices that have significant amount of tracking assets, including estimates of passive buy/sell flow on the stocks. The service also provides commentary and impact of market consultations, ground rule changes, and other events (IPOs, spin-offs, M&A) that could lead to index changes and passive flow.

Periscope Analytics works with multi-strategy hedge funds, proprietary trading firms, stat arb trading groups and long-only investors that invest and trade in the Asia Pacific region with the data being used to trade index rebalances, avoid pre-positioning and passive flow, and to time entry into and exit from stocks.

Event-Driven Trades Across Asia Pacific

Index Rebalance

<ul>
<li>Following two periods of profitability, <a href="https://www.smartkarma.com/entities/innovent-biologics-inc" target="_blank" data-smartkarma-citation="entities:27452:1" rel="noopener">Innovent Biologics Inc (1801 HK)</a> will be added to the <a href="https://www.smartkarma.com/entities/hong-kong-hang-seng-index" target="_blank" data-smartkarma-citation="entities:22899:1" rel="noopener">Hang Seng Index (HSI INDEX)</a> at the close on 5 December.</li>
<li>
<a href="https://www.smartkarma.com/entities/innovent-biologics-inc" target="_blank" data-smartkarma-citation="entities:27452:1" rel="noopener">Innovent Biologics Inc (1801 HK)</a> is also an add to the <a href="https://www.smartkarma.com/entities/hang-seng-china-enterprises-index" target="_blank" data-smartkarma-citation="entities:22900:1" rel="noopener">Hang Seng China Enterprises Index (HSCEI INDEX)</a> in December, so this inclusion increases the flow and impact.</li>
<li>Estimated one-way turnover is 2.3% and the estimated round-trip trade is HK$9.2bn (US$1.2bn). Big capping outflows for <a href="https://www.smartkarma.com/entities/alibaba-group-holding-ltd-d7b798e2-202d-4e01-9a1e-799e2ae8f0c7" target="_blank" data-smartkarma-citation="entities:28434:1" rel="noopener">Alibaba (9988 HK)</a> at the December rebalance.</li>
</ul>


Following two periods of profitability, Innovent Biologics Inc (1801 HK) will be added to the Hang Seng Index (HSI INDEX) at the close on 5 December.

Innovent Biologics Inc (1801 HK) is also an add to the Hang Seng China Enterprises Index (HSCEI INDEX) in December, so this inclusion increases the flow and impact.
Estimated one-way turnover is 2.3% and the estimated round-trip trade is HK$9.2bn (US$1.2bn). Big capping outflows for Alibaba (9988 HK) at the December rebalance.


Hang Seng Index (HSI) Rebalance: Innovent Biologics Turns a Profit, Gets Added

China

Zijin Mining Group Co., Ltd., through its subsidiaries, explores, mines, produces, refines, and sells gold and other mineral resources in China.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Zijin Mining Group Co Ltd H (2899 HK)

Zijin Mining (601899.SS): Acquires Kazakhstan’s Raygorodok Gold Mine for USD 1.2 Billion

Zijin acquires Kazakhstan's Raygorodok gold mine, boosting reserves and production while enhancing profitability and scale.

Rahul Jain

Zijin Mining (2899 HK): Fair Value Still 25% Higher Despite IPO Discount Risks

Zijin plans IPO for overseas gold unit, aiming for 85t output by 2025; stock undervalued with potential for 25-26% upside.

Rahul Jain

Zijin Mining (601899 CH / 2899 HK): Evaluating the Impact of Kakula Suspension

Potential Kakula disruption could impact Zijin's copper output and EBITDA, but ramp-ups at other sites and growth in lithium could partially...

Rahul Jain

Predictive: Perseus Pitches Preferred Proposal

Robex has limited options. PRU will just up the ante and block any attempt to wrangle "superior" terms. If you can take down borrow cheaply, look...

David Blennerhassett

Hang Seng Index (HSI) Rebalance: Innovent Biologics Turns a Profit, Gets Added

Innovent Bio is an add in Dec. Estimated one-way turnover is 2.3% and round-trip trade is HK$9.2bn. Innovent Bio has also been added to the HSCEI,...

Brian Freitas

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)

Zijin Mining (601899.SS): Acquires Kazakhstan’s Raygorodok Gold Mine for USD 1.2 Billion

​Zijin acquires Kazakhstan's Raygorodok gold mine, boosting reserves and production while enhancing profitability and scale.

Rahul Jain

Zijin Mining (2899 HK): Fair Value Still 25% Higher Despite IPO Discount Risks

​Zijin plans IPO for overseas gold unit, aiming for 85t output by 2025; stock undervalued with potential for 25-26% upside.

Rahul Jain

Zijin Mining (601899 CH / 2899 HK): Evaluating the Impact of Kakula Suspension

​Potential Kakula disruption could impact Zijin's copper output and EBITDA, but ramp-ups at other sites and growth in lithium could partially...

Rahul Jain

Predictive: Perseus Pitches Preferred Proposal

Robex has limited options. PRU will just up the ante and block any attempt to wrangle "superior" terms. If you can take down borrow cheaply, look...

David Blennerhassett

Hang Seng Index (HSI) Rebalance: Innovent Biologics Turns a Profit, Gets Added

Innovent Bio is an add in Dec. Estimated one-way turnover is 2.3% and round-trip trade is HK$9.2bn. Innovent Bio has also been added to the HSCEI,...

Brian Freitas

Zijin acquires Kazakhstan's Raygorodok gold mine, boosting reserves and production while enhancing profitability and scale.

Zijin plans IPO for overseas gold unit, aiming for 85t output by 2025; stock undervalued with potential for 25-26% upside.

Potential Kakula disruption could impact Zijin's copper output and EBITDA, but ramp-ups at other sites and growth in lithium could partially...